We are live on ! Find out more
SRGA

Surgalign Holdings, Inc. Common Stock

Delisted

SRGA was delisted on the 30th of June, 2023.

109 hedge funds and large institutions have $177M invested in Surgalign Holdings, Inc. Common Stock in 2017 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 36 increasing their positions, 31 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 12

16% more repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 31

6% more funds holding

Funds holding: 103109 (+6)

9% less capital invested

Capital invested by funds: $193M → $177M (-$16.5M)

33% less funds holding in top 10

Funds holding in top 10: 32 (-1)

Holders
109
Holders Change
+6
Holders Change %
+5.83%
% of All Funds
2.47%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.05%
New
18
Increased
36
Reduced
31
Closed
12
Calls
$88K
Puts
Net Calls
+$88K
Net Calls Change
-$142K
Name Holding Trade Value Shares
Change
Change in
Stake
SG Americas Securities
76
SG Americas Securities
New York
$113K +$126K +919 New
CAM
77
ClariVest Asset Management
California
$104K
TRCT
78
Tower Research Capital (TRC)
New York
$99K +$7.96K +58 +8%
BGIM
79
Brandywine Global Investment Management
Pennsylvania
$96K +$106K +773 New
PPCM
80
Pillar Pacific Capital Management
California
$93K -$2.75K -20 -3%
CS
81
Credit Suisse
Switzerland
$83K -$90.9K -662 -50%
CWM
82
Circle Wealth Management
New Jersey
$82K +$91.6K +667 New
Legal & General Group
83
Legal & General Group
United Kingdom
$61K -$3.43K -25 -5%
Mackenzie Financial
84
Mackenzie Financial
Ontario, Canada
$60K +$20K +146 +43%
JP Morgan Chase
85
JP Morgan Chase
New York
$60K +$66.5K +484 New
PAM
86
Panagora Asset Management
Massachusetts
$55K
CG
87
Caprock Group
Idaho
$53K -$40K -291 -42%
HighTower Advisors
88
HighTower Advisors
Illinois
$48K +$52.6K +383 New
ARTA
89
A.R.T. Advisors
New York
$48K +$53.8K +392 New
BNP Paribas Financial Markets
90
BNP Paribas Financial Markets
France
$48K +$25.5K +186 +91%
Jane Street
91
Jane Street
New York
$47K +$52.5K +382 New
ZCM
92
Zebra Capital Management
Connecticut
$46K +$51.2K +373 New
Principal Financial Group
93
Principal Financial Group
Iowa
$43K
MLICM
94
Metropolitan Life Insurance Company (MetLife)
New York
$41K -$137K -998 -75%
Barclays
95
Barclays
United Kingdom
$36K +$34.2K +249 +579%
Parallax Volatility Advisers
96
Parallax Volatility Advisers
California
$35K +$38.6K +281 New
MIM
97
MetLife Investment Management
New Jersey
$34K +$37.5K +273 New
FQ
98
First Quadrant
California
$26K
Royal Bank of Canada
99
Royal Bank of Canada
Ontario, Canada
$22K -$22K -160 -48%
US Bancorp
100
US Bancorp
Minnesota
$18K -$14K -102 -41%

SRGA Hedge Fund Activity: Q4 2017 in Review

109 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Surgalign Holdings, Inc. Common Stock (SRGA) for Q4 2017, worth a combined $177M — down 8.5% from $193M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new SRGA positions and 12 closed out — a net gain of 6 holders — while 36 added to existing stakes and 31 trimmed.

The largest buyer was Millennium Management, adding an estimated $1.37M. The largest seller was Rutabaga Capital Management, cutting an estimated $3.68M.

  • 109 institutional investors held Surgalign Holdings, Inc. Common Stock (SRGA) as of Q4 2017, up from 103 in Q3 2017.
  • Funds reported $177M of Surgalign Holdings, Inc. Common Stock stock for Q4 2017, down 8.5% quarter-over-quarter.
  • 18 funds opened new Surgalign Holdings, Inc. Common Stock positions in Q4 2017 and 12 closed out, a net change of +6 holders.
  • The largest Surgalign Holdings, Inc. Common Stock buyer in Q4 2017 was Millennium Management, an estimated $1.37M added.
  • The largest Surgalign Holdings, Inc. Common Stock seller in Q4 2017 was Rutabaga Capital Management, an estimated $3.68M sold.

Based on aggregated 13F filings for Q4 2017.